Research-Driven Startup Formation Expands Globally as Venture Capital Presence Falls to 0.5%

InnoDexis has published its latest Innovation Intelligence Report covering global startup formation trends, analyzing 4,389 innovation signals across multiple domains and countries. The report reveals that only 3.9% of these signals point to startups, with 181 startups identified across 23 countries. The findings indicate a structural shift in startup creation, where formation is increasingly driven by research institutions and collaborative ecosystems rather than traditional venture capital pathways, with VC participation appearing in just 0.5% of cases.

Key Findings

Out of 4,389 innovation signals analyzed, only 3.9% correspond to startup activity, highlighting the relatively small proportion of formal company formation within the broader innovation landscape. This indicates that startup creation represents a selective outcome within a much larger pool of research and prototype development.

A total of 181 startups were identified across 23 countries, with a significant proportion originating from research institutions. This distribution suggests that universities and research centers are functioning as primary sources of new venture creation, rather than startups emerging predominantly from independent entrepreneurial or venture-led ecosystems.

The funding structure associated with these startups shows a distinct shift away from venture capital. Government grants account for 38% of support, while research and development collaborations represent 62%, compared to venture capital participation of just 0.5%. This indicates that early-stage development is being sustained through institutional and public funding mechanisms.

Life sciences account for more than 50% of identified startups, with biotechnology and pharmaceutical domains leading formation activity. This concentration reflects the strong alignment between research-intensive fields and startup emergence, particularly in areas requiring significant scientific validation.

A subset of 60 “converged signals,” defined as instances where startup formation coincides with prototype development, represents a key indicator of near-term commercialization potential. These signals suggest a closer alignment between research output and market translation.

Strategic Insight and Trend Analysis

The data indicates a structural shift in how startups are formed within the global innovation ecosystem. Rather than originating from venture capital-driven pipelines, startups are increasingly emerging from research environments where scientific discovery, prototyping, and institutional collaboration converge.

The low visibility of venture capital participation—at 0.5%—suggests that capital is entering the innovation lifecycle at a later stage, after foundational technologies have been validated through publicly funded research and collaborative development. This implies that the earliest phases of startup creation are now occurring largely outside traditional investment channels.

The prominence of life sciences within startup formation further reinforces this trend. Fields such as biotechnology and pharmaceuticals typically require extensive research infrastructure, regulatory validation, and long development timelines, making them well-suited to institution-led formation models.

Geographic patterns provide additional insight into this shift. In the United States, university ecosystems are acting as primary engines of startup formation, translating academic research into commercial entities. In Germany, applied research frameworks are facilitating the transition from scientific development to industrial startup creation. Switzerland, while generating fewer startups overall, demonstrates a higher concentration of disruptive innovation intensity within its ecosystem.

Collectively, these patterns indicate a reordering of the startup formation process. The transition from research to spin-off to collaboration-driven development suggests that value creation is increasingly embedded within early-stage scientific activity, rather than being initiated by capital deployment.

Global and Industry Implications

For corporates and R&D teams, the findings highlight the importance of engaging directly with research institutions and collaborative networks to access early-stage innovation. Traditional partnership models may need to expand to include earlier involvement in prototype and spin-off development.

For investors and capital allocators, the data suggests that relying solely on venture capital signals may limit visibility into high-potential opportunities. Early-stage innovation may increasingly be identified through research outputs and institutional collaborations rather than funding rounds.

For policymakers and national innovation bodies, the shift toward research-driven startup formation underscores the role of public funding and institutional frameworks in enabling commercialization. Supporting pathways from research to spin-off creation may be critical for sustaining innovation-driven economic growth.

InnoDexis Statement

The emergence of startups from research ecosystems rather than venture pipelines indicates a structural shift in how early-stage value is created, with institutional collaboration and scientific validation preceding capital deployment,” noted InnoDexis in its latest intelligence report.

Conclusion

The analysis of 4,389 innovation signals highlights a global transition in startup formation, where research ecosystems are becoming the primary origin of new ventures. With limited venture capital visibility and strong reliance on public funding and collaboration, the early stages of innovation are increasingly decoupled from traditional investment pathways. Monitoring how these research-driven startups progress toward commercialization will be critical in understanding future innovation dynamics. The complete Startup Formation Innovation Intelligence Report is available to InnoDexis subscribers and enterprise clients.

About InnoDexis

InnoDexis is a global Innovation Intelligence platform that tracks, analyzes, and interprets breakthrough innovations, prototypes, and emerging technologies across industries and countries. Its intelligence helps corporates, investors, and policymakers understand the true structure and direction of global innovation. Learn more at innodexis.ai.